MENU

AVBP

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

ArriVent BioPharma (AVBP) Ownership - Who owns ArriVent BioPharma?

ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

18 Campus Boulevard

Phone

+1 628 277-4836

Employees

77

Web

https://www.arrivent.com

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

1.52B

P/E Ratio

N/A

Total Cash

326.38M

Projected Growth

N/A

Total Debt

419K

Revenue

N/A

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash/Share

7.01

Total Debt/Equity

N/A

Revenue/Share

null USD as % of share price

View a ticker or compare two or three

VS

VS

AVBP

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for AVBP

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Details

Industry

N/A

Address

18 Campus Boulevard

Phone

+1 628 277-4836

Employees

77

Web

https://www.arrivent.com